Redistribution of body composition in patients with Graves' disease after iodine-131 treatment

被引:5
|
作者
Xie, L-J [1 ]
Zhou, H-J [2 ]
Li, J-F [1 ]
Zhang, F. [1 ]
Zeng, F-W [1 ]
Qin, L-P [1 ]
Chen, Y. [1 ]
Yuan, H-J [1 ]
Cheng, M-H [1 ]
机构
[1] Sun Yat Sen Univ, Dept Nucl Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Internal Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
关键词
X-RAY ABSORPTIOMETRY; SERUM LEPTIN LEVELS; SKELETAL-MUSCLE; MASS INDEX; THYROID-HORMONE; RADIOIODINE TREATMENT; ENERGY-EXPENDITURE; HYPERTHYROIDISM; BONE; HYPOTHYROIDISM;
D O I
10.1038/ejcn.2014.232
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
OBJECTIVE: The objective of this study was to investigate body composition redistribution at 3 months after radioactive iodine therapy (RAI). METHODS: Eighty patients with Graves' disease (GD) for RAI and 18 volunteers were recruited. All patients underwent thyroid status test and dual-energy x-ray absorptiometry at baseline and 3 months after RAI. According to the second thyroid status test, patients were divided into the following groups: A, with aggravated hyperthyroidism; B-1, with improved hyperthyroidism; B-2, with euthyroidism; and B-3, with hypothyroidism. RESULTS: Total lean mass (LM) but fat mass (FM) and bone mineral content (BMC) of whole GD patients after RAI recovered to be not different with controls. Compared with baseline, in group A, FM in the left leg increased, and LM in left arm, right arm, trunk and total LM decreased (P<0.05). In B-2, FM in the head increased, and LM in the head, right arm, trunk and total LM increased (P<0.05). In B-3, FM in the right leg and total body fat percentage decreased, but FM in the head, android-to-gynoid fat ratio and body mass index increased (P<0.05); LM of all sites, weight and total mass increased (P<0.05); BMC in lumbar spine and left leg, and total BMC decreased (P<0.05). Body composition of unmentioned sites was retained after RAI in each group (P>0.05). CONCLUSIONS: Replenishment of LM gets priority rather than FM and BMC during the first 3 months after RAI, and the increase in LM starts from the upper body; head is the regional site in which FM recovery occurs first.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 50 条
  • [1] Body composition changes in patients with differentiated thyroid cancer after iodine-131 treatment and short-term levothyroxine replacement and suppression therapy
    Wang, Ru
    Qin, Shanshan
    Qiao, Tingting
    Jiang, Wen
    Tong, Junyu
    Lu, Ganghua
    Gao, Dingwei
    Zhang, Mengyu
    Lv, Zhongwei
    Li, Dan
    Chai, Li
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2024, 23 (02): : 257 - 265
  • [2] Iodine-131 therapy alters the immune/inflammatory responses in the thyroids of patients with Graves' disease
    Du, Wenhua
    Dong, Qingyu
    Lu, Xiaoting
    Liu, Xiaomeng
    Wang, Yueli
    Li, Wenxia
    Pan, Zhenyu
    Gong, Qian
    Liang, Cuige
    Gao, Guanqi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (03) : 1155 - 1159
  • [3] Influence of Propylthiouracil and Methimazole Pre-treatment on the Outcome of Iodine-131 Therapy in Hyperthyroid Patients with Graves' Disease
    Shi, G-M
    Xu, Q.
    Zhu, C-Y
    Yang, Y-L
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (02) : 576 - 582
  • [4] Does the dose of iodine-131 influence the incidence of Graves' ophthalmopathy?
    Khiyani, Neeraj
    Dadparvar, Simin
    Gish, Aaron
    Intenzo, Charles M.
    Malmud, Leon S.
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (05) : 455 - 460
  • [5] Acute myeloid leukemia after iodine-131 treatment for thyroid disorders
    L. Laurenti
    P. Salutari
    S. Sica
    N. Piccirillo
    G. Zini
    M. Zollino
    G. Leone
    Annals of Hematology, 1998, 76 : 271 - 272
  • [6] Evaluation of body weight in patients with Graves' disease during the treatment with methimazole
    Moretto, Renata Loureiro
    Pedro, Ana Beatriz P.
    Leite, Alex Carvalho
    Romaldini, Joao Hamilton
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2012, 56 (06) : 364 - 369
  • [7] Acute myeloid leukemia after iodine-131 treatment for thyroid disorders
    Laurenti, L
    Salutari, P
    Sica, S
    Piccirillo, N
    Zini, G
    Zollino, M
    Leone, G
    ANNALS OF HEMATOLOGY, 1998, 76 (06) : 271 - 272
  • [8] Predictive factors for the outcomes of Graves' disease patients with radioactive iodine (131I) treatment
    Xing, Yu-Zhuo
    Zhang, Kun
    Jin, Gang
    BIOSCIENCE REPORTS, 2020, 40
  • [9] Treatment of hyperthyroidism with iodine-131: A propos of 280 cases
    El Issami, S.
    Sarroukh, F.
    Elrhoul, M.
    Guerrouj, H.
    Ghfir, I.
    Aouad, N. Ben Rais
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2011, 35 (10): : 528 - 532
  • [10] The Evaluation of Patients with Hyperthyroidism Treated with Radioactive Iodine-131
    Basibuyuk, Mustafa
    Elboga, Umut
    Celen, Y. Zeki
    Kalender, Ebuzer
    Demir, H. Deniz
    Sahin, Ertan
    Ozkaya, Mesut
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2015, 6 : 58 - 61